DR. SASHANK REDDY, MD, PHD
Radiology at Marlborough St, Boston, MA
License number
Massachusetts 2754
Category
Radiology
Type
Plastic and Reconstructive Surgery
Address
Address
373 Marlborough St UNIT 2, Boston, MA 02115
Phone
(410) 946-1032
Personal information
See more information about SASHANK REDDY at radaris.comName
Address
Phone
Boston, MA
373 Marlborough St, Boston, MA 02115
31 Concord Ave, Cambridge, MA 02138
393 Marlborough St, Boston, MA 02115
Professional information
Dr. Sashank Reddy, Boston MA - MD (Doctor of Medicine)
Specialties:
Plastic Surgery
Address:
373 Marlborough St SUITE 2, Boston 02115
(410) 946-1032 (Phone)
(410) 946-1032 (Phone)
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 2005
Harvard Medical School
Graduated: 2005
Methods And Compositions For Reducing Stemness In Oncogenesis
US Patent:
2011004, Feb 24, 2011
Filed:
Aug 9, 2010
Appl. No.:
12/852973
Inventors:
David A. Berry - Brookline MA, US
Eric J. Devroe - Malden MA, US
Noubar B. Afeyan - Lexington MA, US
Brett Chevalier - Malden MA, US
Sashank K. Reddy - Boston MA, US
Eric J. Devroe - Malden MA, US
Noubar B. Afeyan - Lexington MA, US
Brett Chevalier - Malden MA, US
Sashank K. Reddy - Boston MA, US
International Classification:
A61K 51/00, C12N 5/09, A61K 39/395, A61K 31/7105, A61K 49/00, C12N 5/095, A61K 31/7088, A61P 35/00
US Classification:
424 111, 435375, 4241301, 514 44 A, 424 92
Abstract:
The invention provides methods and compositions for reducing the number of cancer stem cells in a mixed population of differentiated cells (for example, cancer cells) and cancer stem cells. The cancer stem cells, if present, can be more resistant to traditional drug-based therapies and can provide a source for new, differentiated cancer cells associated with the development of drug-resistance and more aggressive phenotypes. When combined with traditional cancer therapies, for example, drug-based therapies, the methods and compositions of the invention provide a more effective way for treating cancer and can provide a model system for developing new cancer therapies and new treatment modalities.
Methods And Compositions For Reducing Stemness In Oncogenesis
US Patent:
2009004, Feb 19, 2009
Filed:
Jul 11, 2008
Appl. No.:
12/171923
Inventors:
David A. Berry - Brookline MA, US
Eric J. Devroe - Malden MA, US
Noubar Boghos Afeyan - Lexington MA, US
Brett Chevalier - Malden MA, US
Sashank K. Reddy - Boston MA, US
Eric J. Devroe - Malden MA, US
Noubar Boghos Afeyan - Lexington MA, US
Brett Chevalier - Malden MA, US
Sashank K. Reddy - Boston MA, US
International Classification:
A61K 39/395, C12N 5/08, A61K 31/7105, A61P 31/00
US Classification:
4241741, 435377, 514 44, 4241781
Abstract:
The invention provides methods and compositions for reducing the number of cancer stem cells in a mixed population of differentiated cells (for example, cancer cells) and cancer stem cells. The cancer stem cells, if present, can be more resistant to traditional drug-based therapies and can provide a source for new, differentiated cancer cells associated with the development of drug-resistance and more aggressive phenotypes. When combined with traditional cancer therapies, for example, drug-based therapies, the methods and compositions of the invention provide a more effective way for treating cancer and can provide a model system for developing new cancer therapies and new treatment modalities.
Il-17 Family Cytokine Compositions And Uses
US Patent:
2013006, Mar 14, 2013
Filed:
Oct 11, 2010
Appl. No.:
13/501244
Inventors:
Thomas M. Barnes - Cambridge MA, US
Michael M. Schmidt - Cambridge MA, US
Bracken M. King - Cambridge MA, US
K. Christopher Garcia - Menlo Park CA, US
Sashank Reddy - Boston MA, US
Gregory James Sieczkiewicz - Hopkinton MA, US
Lauren K. Ely - Palo Alto CA, US
Michael M. Schmidt - Cambridge MA, US
Bracken M. King - Cambridge MA, US
K. Christopher Garcia - Menlo Park CA, US
Sashank Reddy - Boston MA, US
Gregory James Sieczkiewicz - Hopkinton MA, US
Lauren K. Ely - Palo Alto CA, US
Assignee:
Eleven Biotherapeutics, Inc. - Cambridge MA
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 38/20, C12P 21/02, C12N 5/10, C12N 1/21, A61P 29/00, C12N 1/19, C07K 14/54, C07K 16/24, C07H 21/04, A61P 37/02, A61K 39/395, C12N 1/15
US Classification:
424 852, 4241391, 435 691, 435 6952, 435 696, 435325, 435348, 435366, 435419, 43525231, 43525233, 43525234, 43525411, 4352542, 43525421, 43525423, 530351, 5303879, 536 234, 536 235, 536 2353
Abstract:
Binding proteins, including non-naturally occurring and recombinantly modified proteins that bind to an IL-17R and including proteins having a mutated IL-17 cytokine sequence, methods of making such molecules and methods of using such molecules as therapeutic, prophylactic and diagnostic agents are provided.
Cytokine Compositions And Methods Of Use Thereof
US Patent:
2012026, Oct 25, 2012
Filed:
Jul 26, 2010
Appl. No.:
13/386652
Inventors:
K. Christopher Garcia - Menlo Park CA, US
Patrick Lupardus - Menlo Park CA, US
Sashank K. Reddy - Boston MA, US
Gregory J. Sieczkiewicz - Hopkinton MA, US
Patrick Lupardus - Menlo Park CA, US
Sashank K. Reddy - Boston MA, US
Gregory J. Sieczkiewicz - Hopkinton MA, US
International Classification:
A61K 38/20, C07K 19/00, C12N 15/24, C12N 15/62, C07K 16/24, A61K 39/395, A61P 29/00, A61P 17/06, A61P 19/02, A61P 1/04, A61P 25/00, C12P 21/02, C12N 5/071, C12N 5/10, C07K 14/54
US Classification:
424 852, 530351, 536 235, 536 234, 5303892, 4241581, 435 6952, 435375, 435348, 435369, 435328
Abstract:
Polypeptides, including non-naturally occurring and recombinantly modified polypeptides related to the p19 subunit of IL-23, methods of making such molecules and methods of using such molecules as therapeutic, prophylactic and diagnostic agents are provided.